Wikidata

(Q64150503)

English

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

clinical trial

In more languages

Statements

short name
ECZTRA 5 (English)
0 references
title
A Randomised, Double-blind, Placebo-controlled Trial to Evaluate the Effect of Tralokinumab on Vaccine Antibody Responses in Adults With Moderate-to-severe Atopic Dermatitis Who Are Candidates for Systemic Therapy (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
sponsor
LEO Pharma
0 references
country
Canada
0 references
start time
13 July 2018
0 references
end time
4 July 2019
0 references
number of participants
212
0 references
minimum age
18 year
0 references
maximum age
54 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150503&oldid=1857571485"